PTC Therapeutics PTCT Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by PTC Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about PTC Therapeutics's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is PTC Therapeutics's operating income?
- PTC Therapeutics (PTCT) reported operating income of $44.96M in Q1 2026.
- How has PTC Therapeutics's operating income changed year-over-year?
- PTC Therapeutics's operating income decreased by 95.4% year-over-year, from $970.23M to $44.96M.
- What is the long-term trend for PTC Therapeutics's operating income?
- Over 4 years (2021 to 2025), PTC Therapeutics's operating income has grown at a 25.8% compound annual growth rate (CAGR), from -$374.45M to $938.28M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.